An initial PINGS pilot trial performed by Ovbiagele’s group in Ghana demonstrated the feasibility of deploying a nurse-guided ...

Our most-read articles explore “occlusion MI” versus STEMI, TAVI in asymptomatic AS, and highlights from recent conferences.

Researchers say the data further support the use of an FFR-first strategy in treating intermediate coronary lesions.

The lower rate of net adverse clinical events was driven by less bleeding in those on 1 month of prasugrel-based DAPT.

HELSINKI, Finland—It may be possible to safely cut back on the level of monitoring performed in select patients with acute ...

OCT seems to reduce periprocedural MI, a benefit not seen in the chronic coronary syndrome patients that deserves further ...

Relying on iFR/FFR values from the LCx alone could mean many patients with left main disease miss out on revascularization.

Researchers used PET/MRI to detect otherwise invisible inflammation. Less clear is how this might influence patient care.

The explanation for why the valve failed is too little, too late: Boston Scientific ended global sales of the device ...

Based on these numbers, the researchers estimated that 5-year cumulative risks of recurrent events were 17.4% for ischemic ...

The findings hint at why the ABYSS trial failed to show it was safe to stop beta-blockers after an MI in stable patients.

A sex gap seen in quality of life deserves further scrutiny, but the DISCHARGE trial data are still reassuring, says Maros ...